Molina Healthcare Raises 2026 Adjusted EPS Guidance to at Least $5.25
MOH sits 77% above its 52-week low of $121.06.
Summary
Molina Healthcare raised its 2026 adjusted earnings guidance by $0.25 to at least $5.25 per diluted share, signaling improved profitability expectations. This follows a challenging Q1 where EPS fell 95% and premium revenue declined 4%, making the upward revision a notable reversal. The increase suggests management sees better cost trends or revenue growth in the back half of the year. With the stock at $213.88, the new guidance implies a forward P/E of roughly 40x, still demanding but improved. The company's recent Medicaid contract win in Illinois and ambitious 2029 targets from its May Investor Day provide additional context for the positive outlook.
At the time of this announcement, MOH was trading at $213.89 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.9B. The 52-week trading range was $121.06 to $244.89. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.